Abstract
The discovery of hypercalciuria after a nephrolithiasis or among biological tests for osteoporosis requires a clinical and biological careful investigation to search for primary hyperparathyroidism or excessive intake of vitamin D, calcium, salt, alcohol or proteins of animal origin. In osteoporosis, the discovery of idiopathic hypercalciuria does not change the usual therapeutic care, ensuring appropriate calcium intake not exceed 800mg per day. After nephrolithiasis, if dietary therapy is insufficient, the prescription of hydrochorothiazide is possible with checking regularly the biological effectiveness and tolerance.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
